Saxena U, Ramesh V, Misra R S, Mukherjee A
Institute of Pathology (ICMR), New Delhi.
Lepr Rev. 1991 Jun;62(2):206-11. doi: 10.5935/0305-7518.19910025.
Three patients of histopathologically confirmed borderline-tuberculoid leprosy showing no acid-fast bacilli and with lesions confined to the face, 2 on the cheek and 1 on the forehead, were given multidrug therapy as recommended by the WHO for paucibacillary cases. Within 3 months the lesions showed signs of upgrading (or reversal) reaction which was substantiated by histopathology. In 1 patient the facial nerve was affected leading to facial palsy. The lymphocyte transformation test did not show a significant rise. All 3 patients were given oral prednisolone for periods varying between 5 and 7 months, but the response was poor except in 1 patient in whom the facial palsy responded favourably. Injections of sodium antimony gluconate tried in 1 patient after stoppage of steroids did not control the reaction. After 18 months of regular follow-up during therapy, the cutaneous reaction in the patient with facial nerve involvement subsided leaving significant atrophy. However, in the other 2 patients the skin lesion persisted with clinical and histopathological evidence of upgrading reaction. The reasons for the unnatural persistence of reaction in these patients is not clear.
三名组织病理学确诊为界线类偏结核样型麻风的患者,未发现抗酸杆菌,病变局限于面部,2例在脸颊,1例在前额,按照世界卫生组织推荐的少菌型病例方案接受了多药治疗。3个月内,病变出现升级(或逆转)反应迹象,组织病理学证实了这一点。1例患者面神经受累导致面瘫。淋巴细胞转化试验未显示明显升高。所有3例患者均口服泼尼松龙5至7个月不等,但除1例面瘫患者反应良好外,其余反应不佳。1例患者在停用类固醇后尝试注射葡萄糖酸锑钠,但未能控制反应。治疗期间定期随访18个月后,面神经受累患者的皮肤反应消退,但留下明显萎缩。然而,另外2例患者的皮肤病变持续存在,有临床和组织病理学证据显示存在升级反应。这些患者反应异常持续的原因尚不清楚。